1 / 24

Importance of operational grip on cancer recovery The journey from despair to hope to success .

Importance of operational grip on cancer recovery The journey from despair to hope to success. Introduction. Where were we? IST support A few simple changes helped turn cancer performance around Focused support on challenged areas Culture change “We’re taking cancer seriously”

butler
Download Presentation

Importance of operational grip on cancer recovery The journey from despair to hope to success .

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Importance of operational grip on cancer recovery The journey from despair to hope to success.

  2. Introduction • Where were we? • IST support • A few simple changes helped turn cancer performance around • Focused support on challenged areas • Culture change “We’re taking cancer seriously” • Going from failing 2ww and 62 day to passing 3 quarters in a row • Still got a way to go! RBH

  3. Background • Failing performance • High numbers on the PTL • High number of interim managers • Turnover in cancer team • Dermatology issue • Clinical Admin Team (CAT) restructure + turnover • Acceptance RBH

  4. IST involvement • Demand & Capacity Review on 1st OPA, Diagnostic and IP wait • Advice around PTL meeting • Attendees • Format • Expectations • Training • Support on content and delivery RBH

  5. Turning point • Demand & Capacity work complete and capacity on line and gap quantified. • Expectation that 2ww performance should be sorted for Quarter 1 2016. • Reality – at the end of April we had 268 breaches = whole quarter tolerance gone by end of the first month. • Agreed an ambitious but realistic goal of passing 62 day by Quarter 3 2016 RBH

  6. Process • Pathway divided into a logical approach: • 2WW • Diagnostics • 62 Day • Quarterly trajectories by IST reflected this approach • Trust CCG and NHSI approved the trajectories RBH

  7. Relationship management • Cancer Action Group • Weekly meeting, very quick • Chief Operating Officer, Planned Care Leaders, Cancer Pathways Manager, Access Manager, Service Managers as required • Discuss performance and predicted performance, decide short term action and support long term action • CCG transparency • Monthly executive led meetings including performance leads – less reactive reporting and a more transparent approach • Led by Chief Operating Officer • Open and challenging forum • Quarterly trajectories agreed with the NHSI / NHSE RBH

  8. Gaining operational grip- 2WW • Daily Cancer Ops Meeting • Very quick • Snapshot of breaches and referrals • Attended by all specialties ranging from Booking Officer to Service Manager • Senior Chair • Visual management, high impact • Very quick to set up • Iterative! • Engaged and empowered teams who can own the pathway RBH

  9. RBH

  10. Gaining grip- 2WW • Open conversations with patients about choice to reduce cancellations Your GP has referred you very urgently to exclude a potentially serious issue such as cancer. We strongly advise you to accept this appointment. • 88 2ww choice breaches in April ’16 – 89.5% • 39 2ww total breaches in June ’16 – 97.2% • Lowest performing month since was Sept ’16 – 69 choice breaches, 95.1% • 1 complaint • “Aim for 7 days to achieve 14” RBH

  11. Gaining grip - Radiology • Getting priority clear for diagnostics • Amended PAS order priority • Changed from “2ww” to “2ww suspected cancer” • Reduced inappropriate use of the 2ww priority and capacity • Allowed services to prioritise the 2ww booking process • Much clearer demand for true 62 day patients • Push to get diagnostics through in 7 days RBH

  12. Gaining grip – Endoscopy • Endoscopy weekly meeting • Attended by clinicians, nurses and management • Additional management support • High clinical engagement • Problems broken down into manageable chunks • Structured and well supported • Most problems were solved by the service teams • Prioritised and visible demand managed by an empowered team RBH

  13. Gaining Grip - 62 Day • Focus of tracking changed • Decrease in number of active patients on PTL – Jan 2016 saw over 2000 patients compared to now, between 1200-1400 patients. • Infoflex updated to fit our tracking needs • PTL meetings re-launched and given top priority • Every patient discussed • Come with completed actions • Up-to-date • Business as usual RBH

  14. Gaining Grip - 62 Day RBH

  15. Gaining Grip – Long Waiters • 104 day patients • Reviewed daily and actively managed • Rapid next steps • Escalation • Harm review • Start at day 90 • Clinical Harm Review board launched • Pathway reviewedby Lead Cancer Nurse • Chaired by Medical Director

  16. Gaining Grip - 62 Day • Breach board in MDTC room • White board on the wall • Separated by month, patient initial, site and Hospital number • Any patient at risk of breaching in this month or next • Very visible to whole team • Predict performance RBH

  17. Gaining Grip - 62 Day • IST review of training • Cancer training was introduced beyond the cancer team • All members of the clinical admin teams attended • Continue to be rolled out once a month • Training for the consultants is currently in the planning stages. RBH

  18. Ethos at RBH • Accept no 2WW breach due to capacity • Only accept informed patient choice breaches • Understanding across all staff groups that the standards reflect: • High quality patient care • Improved outcomes • Trust priority for our patients • Achievement of the cancer standards is a good indicator that we are doing right by our patients RBH

  19. Where we are now Current performance Q4: 2ww 96.6%, 62 day 85.7% Yearly performance 16/17: 2ww 95.4%, 62 day 85.02% Continuing to work through: • CT CIN (contrast-induced nephropathy) • Constant updates to our demand and capacity work • Quality of referrals • Vague symptom pathway • Tertiary referrals • Diagnosed by day 28 RBH

  20. 2 Week Wait Performance RBH

  21. 62 Day Performance RBH

  22. Summary • Lots of small changes and a few larger projects • Logical approach broken down into manageable chunks • Focused support, particularly in diagnostics • Culture change regarding patient choice • Constant 2ww growth • Culture change at every level that we will push for continuous improvement. RBH

  23. Laurie Scott Director of Operations Laurie.scott@royalberkshire.nhs.uk Chris Lowrie Directorate Manager Berkshire Cancer Centre Chris.lowrie@royalberkshire.nhs.uk Charlotte Wood Cancer Pathways Manager Charlotte.wood@royalberkshire.nhs.uk

More Related